A UMMS clinical trial found that a simple, high-fiber diet produced clinically significant weight loss, lowered blood pressure and improved insulin resistance—results comparable to those produced by the American Heart Association diet, according to results of the study published in the Annals of Internal Medicine.
UMass Medical School researchers are using CRISPR/Cas9, a powerful gene editing tool, to develop a novel technology that can potentially cut the DNA of the latent HIV virus out of an infected cell.
Scientists at MassBiologics are developing a pre-exposure prophylaxis that prevents tick-transmitted infection of Lyme disease, a breakthrough that could lead to seasonal prevention against the most common tick-borne infection in North America.
UMass Medical School awarded 233 degrees, including two honorary degrees, Sunday, May 31, at its 42nd Commencement exercises. Institute of Medicine President Victor J. Dzau, MD, delivered the keynote address.
New technology being developed by computer scientists at UMass Lowell will be pilot tested by researchers at UMass Medical School in an effort to improve the lives of obese and overweight patients by helping them more accurately record caloric intake.
U.S. Department of Veterans Affairs officials met with Congressman James McGovern and Chancellor Michael F. Collins to further develop the relationship between the two organizations as they work together to expand services to veterans in the Worcester County area.
UMMS reseachers, led by principal investigator Abraham L. Brass, MD, PhD, have identified a new life cycle stage in HIV infection, thanks to a novel technique they developed to take images of intact infected cells.
Massachusetts Gov. Charlie Baker will deliver the commencement address during the 43rd Commencement Exercises at UMass Medical School on Sunday, June 5.
UMass Medical School will invest two faculty members into newly endowed chairs next fall, Chancellor Michael F. Collins has announced. The chairs were approved by the University of Massachusetts Board at its December meeting.
UMass Medical School has received approximately $10 million from the Department of Defense to develop new technologies and strategies that will anticipate and predict drug resistance and susceptibility in influenza. Robert Finberg, MD, is leading the multi-disciplinary team undertaking the research.